#therapies

Collection of therapies news, found 183 news.

Investigational Oral Multiple Sclerosis Therapy Teriflunomide (*) Aubagio (R)) Significantly Reduced

-            - Findings from Two-Year Pivotal Phase III TEMSO Trial ...

More Patients with Type 2 Diabetes Reach HbA[1c] Target with Apidra(R) on top of Lantus(R)

-            - First Randomized Controlled Trial to Show That Basal Plus ...

New ESC Guidelines Recommend Efient(R) (Prasugrel) as First-line Antiplatelet Therapy for Patients w

-    In new guidelines from the European Society of Cardiology (ESC), prasugrel - a once daily oral ...

Effient(R) (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopido

-Analysis evaluated efficacy and safety among three patient sub-groups        A new ...

Eli Lilly India and Lupin Announce Strategic Collaboration to Help Fight the Battle Against Diabetes

-    Eli Lilly India (Lilly) and Lupin Limited (Lupin) today announced they have entered into a ...

New Data Shows Lantus(R) Activation of Insulin Receptor Comparable to Human Insulin

-        - Human and in vivo Studies Indicate Lantus(R) Metabolites do not ...

Lantus(R)/Apidra(R) SoloSTAR(R) Help to Improve Patient Satisfaction

-        Sanofi (EURONEXT: SAN and NYSE: SNY) announced today, at the 71st Scientific ...

Jubilant and Endo Pharmaceuticals Announce Late Stage Discovery Milestone in Oncology Program

-    Jubilant Biosys Ltd., Bengaluru based subsidiary of Jubilant Life Sciences Ltd., and Endo ...

UGM to hold seminar on nutraseutical products

Gadjah Mada University (UGM) will hold a national seminar on the benefits, safety and development prospects of ...

Sanofi's Investigational Semuloparin in Cancer Patients Initiating Chemotherapy Shows a 64 % Risk Re

-        - Results of Phase III SAVE-ONCO Study Selected for "Best of ASCO 2011" ...

Novel First-in-Class Anti-Cancer Agent in Development by Niiki Pharma Shows Promising Phase I Result

- Phase I Data for NKP-1339, a First-in-Class Transferrin Targeted Anti-Cancer Agent to be Presented at Upcoming ...

Procoralan(R) Significantly Improves Quality of Life as Well as Survival

-        Results of a new analysis from the largest-ever morbi-mortality study of ...

2011 ACCF/AHA Guidelines Incorporate New Recommendation for Platelet Reactivity Testing

-    Platelet Function Testing May Be Used to Aid Patient Management    Accumetrics, ...

RI calls on int`l community to cut narcotics demand

Indonesia has called on the international community to cut global demand for narcotics and drugs as part of a ...

Accumetrics Announces Publication of GRAVITAS Primary Results in JAMA

-Evaluation of Alternative Treatment Strategies Incorporating Platelet Function Testing Recommended    ...